The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-Chloro-N-(1-(2-cyanobenzyl)azetidin-3-yl)-3-((3,5-dimethylphenyl)sulfonyl)-1H-indole-2-carboxamide ID: ALA4476732
PubChem CID: 155538659
Max Phase: Preclinical
Molecular Formula: C28H25ClN4O3S
Molecular Weight: 533.05
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(C)cc(S(=O)(=O)c2c(C(=O)NC3CN(Cc4ccccc4C#N)C3)[nH]c3ccc(Cl)cc23)c1
Standard InChI: InChI=1S/C28H25ClN4O3S/c1-17-9-18(2)11-23(10-17)37(35,36)27-24-12-21(29)7-8-25(24)32-26(27)28(34)31-22-15-33(16-22)14-20-6-4-3-5-19(20)13-30/h3-12,22,32H,14-16H2,1-2H3,(H,31,34)
Standard InChI Key: HEUCEWNQBNOMRX-UHFFFAOYSA-N
Molfile:
RDKit 2D
37 41 0 0 0 0 0 0 0 0999 V2000
7.5281 -23.3684 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.9503 -23.9503 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
7.7431 -24.1597 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.5096 -24.9862 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5085 -25.8057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2165 -26.2147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2148 -24.5773 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9234 -24.9826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9236 -25.8012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7023 -26.0540 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1833 -25.3915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7019 -24.7295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8018 -24.5778 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8.0005 -25.3912 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4094 -26.0988 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.4088 -24.6834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4071 -23.3451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6634 -22.5695 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.1172 -21.9627 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3170 -22.1327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0659 -22.9148 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6138 -23.5182 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2672 -23.0878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3698 -21.1856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2266 -26.0985 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8013 -26.6763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3789 -26.0982 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8009 -25.5206 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1961 -26.0979 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6050 -26.8055 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1960 -27.5105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.6042 -28.2175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4223 -28.2177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8304 -27.5049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4199 -26.8007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8214 -26.0910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2265 -25.3813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 2 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
4 13 1 0
11 14 1 0
14 15 1 0
14 16 2 0
12 2 1 0
2 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
21 23 1 0
19 24 1 0
15 25 1 0
25 26 1 0
26 27 1 0
27 28 1 0
28 25 1 0
27 29 1 0
29 30 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
36 37 3 0
35 36 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 533.05Molecular Weight (Monoisotopic): 532.1336AlogP: 4.76#Rotatable Bonds: 6Polar Surface Area: 106.06Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: 9.51CX Basic pKa: 3.61CX LogP: 5.14CX LogD: 5.14Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.37Np Likeness Score: -1.49
References 1. Zhao T, Meng Q, Kang D, Ji J, De Clercq E, Pannecouque C, Liu X, Zhan P.. (2019) Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing., 182 [PMID:31434039 ] [10.1016/j.ejmech.2019.111619 ]